Company: LCTX
Filing Date: 2025-03-10
Form Type: 10-K
Source: 0000950170-25-036309
Chunk: 213

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-03-10
Form: 10-K
Item: Item 1B
Chunk 213
---
12, 2013
     
    001-12830

    10.06(g)+
     
    2012 Plan Stock Option Grant Agreement
     
    10.2
     
    10-Q
     
    November 12, 2019
     
    000-12830

    10.06(h)+
     
    2012 Plan Form of Restricted Stock Unit
     
    10.6
     
    10-K
     
    March 12, 2020
     
    001-12830

    10.07+
     
    Lineage Cell Therapeutics 2021 Equity Incentive Plan, effective as of September 2021 (“2021 Plan”)
     
    10.1
     
    8-K
     
    September 15, 2021
     
    001-12830

    10.07(a)+
     
    Amendment to 2021 Plan effective September 6, 2023
     
    10.01
     
    8-K
     
    September 7, 2023
     
    001-12830

    10.07(b)+
     
    2021 Plan Form of Stock Option Grant Notice and Agreement for Employees and Consultants
     
    99.2
     
    S-8
     
    September 28, 2021
     
    333-259853

    10.07(c)+
     
    2021 Plan Form of Stock Option Grant Notice and Agreement for Non-Employee Directors
     
    99.3
     
    S-8
     
    September 28, 2021
     
    333-259853

    10.07(d)+
     
    2021 Plan Form of Restricted Stock Unit Award Grant Notice and Agreement
     
    99.4
     
    S-8
     
    September 28, 2021
     
    333-259853

    10.08+
     
    Executive Performance Incentive Bonus Plan, adopted September 2022
     
    10.5
     
    10-Q
     
    November 10, 2022
     
    001-12830

    COMMERCIAL AGREEMENTS

    10.09